{"cik":"0001517022","ticker":"AKBA","name":"Akebia Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-05-12","last_filing_date":"2026-05-12","url":"/sec/cik-0001517022","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0000093751-26-000200","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-12","title":"SCHEDULE 13G — Akebia Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001517022/schedule-13g/0000093751-26-000200","edgar_url":"https://www.sec.gov/Archives/edgar/data/1517022/0000093751-26-000200-index.html"}],"related_endpoints":{"profile":"/sec/AKBA/profile","timeline":"/sec/AKBA/timeline","peers":"/sec/AKBA/peers","insider_pulse":"/sec/AKBA/insider-pulse","insider_summary":"/sec/AKBA/insider-summary","insider_transactions":"/sec/AKBA/insider-transactions","form144":"/sec/AKBA/form144","holdings_as_filer":"/sec/AKBA/holdings","financial_facts":"/sec/AKBA/financial-facts","derivatives":"/sec/AKBA/derivatives","officers":"/sec/AKBA/officers","insider_network":"/sec/AKBA/insider-network","risk_flags":"/sec/AKBA/risk-flags","filings":"/sec/AKBA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=AKBA"}}